Financial statements Biosens Labs
Balance sheet of Biosens Labs
Company age:
Age:
5 y. 3 m. 28 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOSENS LABS
|
Year
|
2020
|
2021
|
2022
|
|---|---|---|---|
| Total assets | 1 002 795,07 | 1 524 708,00 | 1 777 512,03 |
| A. Fixed assets | 327 077,45 | 713 358,92 | 1 047 104,46 |
| B. Current assets | 675 717,52 | 811 349,08 | 730 407,57 |
| C. Share capital contributions (basic funds) | 0,10 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 002 795,07 | 1 524 708,00 | 1 777 512,03 |
| A. Equity | 920 722,35 | 64 890,48 | -1 028 257,25 |
| B. Liabilities and provisions for liabilities | 82 072,72 | 1 459 817,52 | 2 805 769,28 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 82 072,72 | 1 369 672,52 | 2 152 427,69 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.